| 51 |
26621498 | Comparison of gut hormones and adipokines stimulated by glucagon test among patients with type II diabetes mellitus after metabolic surgery. | 2016 Feb |
2 |
| 52 |
26681725 | Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. | 2016 Feb |
2 |
| 53 |
26743775 | Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes. | 2016 Apr |
1 |
| 54 |
26837808 | Paracrine regulation of glucagon secretion: the β/α/δ model. | 2016 Apr 15 |
1 |
| 55 |
26861783 | Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes. | 2016 May |
1 |
| 56 |
26965024 | The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs. | 2016 Mar |
1 |
| 57 |
27034187 | Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans. | 2016 Apr |
1 |
| 58 |
27163358 | Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes. | 2016 Jul |
1 |
| 59 |
27399349 | Impaired Follistatin Secretion in Cirrhosis. | 2016 Sep |
1 |
| 60 |
27440478 | Multiplexing Fluorescence Anisotropy Using Frequency Encoding. | 2016 Aug 16 |
1 |
| 61 |
27462585 | Insulin and glucagon levels of umbilical cord blood in appropriate for gestational age - preterm infants with or without postnatal hypoglycemia. | 2016 Jun |
1 |
| 62 |
27504013 | Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation. | 2016 Nov |
5 |
| 63 |
27660134 | Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270. | 2016 Oct |
1 |
| 64 |
27660135 | Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270. | 2016 Oct |
1 |
| 65 |
28702245 | Hyperglucagonemia in an animal model of insulin- deficient diabetes: what therapy can improve it? | 2016 |
1 |
| 66 |
30603256 | Complementary glucagonostatic and insulinotropic effects of DPP-4 inhibitors in the glucose-lowering action in Japanese patients with type 2 diabetes. | 2016 Jun |
3 |
| 67 |
25053587 | Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes. | 2015 Jan |
1 |
| 68 |
25160667 | Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon. | 2015 Jan |
1 |
| 69 |
25328079 | Addition of sitagliptin or metformin to insulin monotherapy improves blood glucose control via different effects on insulin and glucagon secretion in hyperglycemic Japanese patients with type 2 diabetes. | 2015 |
1 |
| 70 |
25406263 | Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic α-cell by lowering cAMP. | 2015 Jan 15 |
3 |
| 71 |
25439266 | Insulin-independent actions of glucagon-like peptide-1 in wethers. | 2015 Apr |
2 |
| 72 |
25655786 | Correlation of circulating betatrophin concentrations with insulin secretion capacity, evaluated by glucagon stimulation tests. | 2015 May |
1 |
| 73 |
25872541 | Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. | 2015 Apr |
2 |
| 74 |
26049639 | Glucagon - the new 'insulin' in the pathophysiology of diabetes. | 2015 Jul |
1 |
| 75 |
26502359 | Role of the Entero-Insular Axis in the Pathogenesis of Idiopathic Reactive Hypoglycemia: A Pilot Study. | 2015 Dec |
1 |
| 76 |
26607818 | Short-term glucagon stimulation test of C-peptide effect on glucose utilization in patients with type 1 diabetes mellitus. | 2015 Dec |
1 |
| 77 |
26666142 | [Significance of the regulation of hyperglucagonemia in type 2 diabetes mellitus]. | 2015 Dec |
1 |
| 78 |
23572405 | Circulating glucagon to ghrelin ratio as a determinant of insulin resistance in hyperthyroidism. | 2014 Feb |
1 |
| 79 |
23902932 | Bed rest worsens impairments in fat and glucose metabolism in older, overweight adults. | 2014 Mar |
2 |
| 80 |
24233056 | Are we overestimating the loss of beta cells in type 2 diabetes? | 2014 Feb |
1 |
| 81 |
24354538 | Glucose-induced inhibition of insulin secretion. | 2014 Mar |
2 |
| 82 |
24373998 | Pharmacokinetic properties and effects of PT302 after repeated oral glucose loading tests in a dose-escalating study. | 2014 Jan 1 |
1 |
| 83 |
24420336 | Association between skeletal muscle mass and insulin secretion in patients with type 2 diabetes mellitus. | 2014 |
1 |
| 84 |
24692138 | Energy metabolism in the liver. | 2014 Jan |
1 |
| 85 |
24735537 | Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells. | 2014 May 16 |
2 |
| 86 |
24741525 | A case report of reactive hypoglycemia in a patient with pheochromocytoma and it's review of literature. | 2014 Mar |
1 |
| 87 |
24909093 | Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin. | 2014 Nov |
2 |
| 88 |
24944132 | Positive effects of football on fitness, lipid profile, and insulin resistance in Brazilian patients with type 2 diabetes. | 2014 Aug |
1 |
| 89 |
24962915 | Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia. | 2014 Jul |
2 |
| 90 |
25024374 | Mitochondrial GTP insensitivity contributes to hypoglycemia in hyperinsulinemia hyperammonemia by inhibiting glucagon release. | 2014 Dec |
1 |
| 91 |
25030779 | Comparison of the effects of slowly and rapidly absorbed carbohydrates on postprandial glucose metabolism in type 2 diabetes mellitus patients: a randomized trial. | 2014 Oct |
1 |
| 92 |
25063274 | Glucagon regulates orexin A secretion in humans and rodents. | 2014 Oct |
1 |
| 93 |
25139882 | Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels. | 2014 Nov |
5 |
| 94 |
25159323 | Arginine is preferred to glucagon for stimulation testing of β-cell function. | 2014 Oct 15 |
1 |
| 95 |
25175981 | Patients with type 2 diabetes mellitus failing on oral agents and starting once daily insulin regimen; a small randomized study investigating effects of adding vildagliptin. | 2014 Aug 29 |
1 |
| 96 |
25239783 | Impact of islet autoimmunity on the progressive β-cell functional decline in type 2 diabetes. | 2014 Dec |
1 |
| 97 |
25289919 | [GLP-1 analogues in treatment of type 1 diabetes mellitus]. | 2014 Oct |
1 |
| 98 |
25344304 | An alteration of the endocrine pancreas involved in cancer. | 2014 Dec |
2 |
| 99 |
25414935 | Safety and efficacy of dulaglutide, a once weekly GLP-1 receptor agonist, for the management of type 2 diabetes. | 2014 Oct |
1 |
| 100 |
22804102 | Potential role of non-insulin adjunct therapy in Type 1 diabetes. | 2013 Feb |
1 |